Citation data

CrossRef

Works that cite this article, indexed by Crossref.

16 resultsUpdated August 09, 2026
1

Recombinant immunotoxins development for HER2-based targeted cancer therapies

Cancer Cell International 21(1) (2021)

Reza Mahmoudi; Hassan Dianat-Moghadam; Mansour Poorebrahim; Samaneh Siapoush; Vahdat Poortahmasebi; Reza Salahlou; Mohammad Rahmati

2

Finding Appropriate Signal Peptides for Secretory Production of Recombinant Glucarpidase: An In Silico Method

Recent Patents on Biotechnology 15(4) (2021)

Omid Vakili; Seyyed Hossein Khatami; Amir Maleksabet; Ahmad Movahedpour; Saeed Ebrahimi Fana; Rasoul Sadegh; Amir Hossein Salmanzadeh; Hadi Razeghifam; Sajjad Nourdideh; Sadra Samavarchi Tehrani; Mortaza Taheri-Anganeh

3

Extracellular Vesicles from Campylobacter jejuni CDT-Treated Caco-2 Cells Inhibit Proliferation of Tumour Intestinal Caco-2 Cells and Myeloid U937 Cells: Detailing the Global Cell Response for Potential Application in Anti-Tumour Strategies

International Journal of Molecular Sciences 24(1) (2022)

Mariele Montanari; Michele Guescini; Ozan Gundogdu; Francesca Luchetti; Paola Lanuti; Caterina Ciacci; Sabrina Burattini; Raffaella Campana; Claudio Ortolani; Stefano Papa; Barbara Canonico

4

Designing a Humanized Immunotoxin Based on Gelonin Against HER2+ Breast Cancer: An In-Silico Study

Brazilian Journal of Pharmaceutical Sciences 62 (2026)

Mahsa Daneshmand; Jamileh Salar Amoli; Mohammad Taheri

5

Suitable Signal Peptides for Secretory Production of Recombinant Granulocyte Colony Stimulating Factor in Escherichia coli

Recent Patents on Biotechnology 14(4) (2020)

Sadra S. Tehrani; Golnaz Goodarzi; Mohsen Naghizadeh; Seyyed H. Khatami; Ahmad Movahedpour; Ali Abbasi; Zahra Shabaninejad; Nesa Khalaf; Mortaza Taheri-Anganeh; Amir Savardashtaki

6

Engineering of Cytolethal Distending Toxin B by Its Reducing Immunogenicity and Maintaining Stability as a New Drug Candidate for Tumor Therapy; an In Silico Study

Toxins 13(11) (2021)

Maryam Keshtvarz; Mahdieh Mahboobi; Marek Kieliszek; Antoni Miecznikowski; Hamid Sedighian; Milad Rezaei; Mohammad Ali Haghighi; Zahra Zareh; Ehsan Rezaei

7

Designing a Humanized Immunotoxin Based on HER2 Specific scFv and DFF40 Toxin Against Breast Cancer: An In-Silico Study

International Journal of Peptide Research and Therapeutics 28(5) (2022)

Ahmad Movahedpour; Khadijeh Ahmadi; Mortaza Taheri-Anganeh; Ahmad Amiri; Nahid Ahmadi; Seyyed Hossein Khatami; Sara Zafaranchi z.m; Elahe Soltani Fard; Mostafa Moazamfard; Hassan Ghasemi; Navid Nezafat

8

Antibody–drug conjugates for infectious and neglected tropical diseases: chemical design principles, target biology, and translational challenges

Frontiers in Chemistry 14 (2026)

Desigan Reddy; Vineet Jeena; Tshephiso R. Papo; Emmanuel C. Ohaekenyem

9

Ribonuclease‐Based Immunotoxins as Anticancer Agents

Biotechnology and Applied Biochemistry 73(2) (2026)

Arezoo Mesri; Negar Asadi; Hadi Maleki‐Kakelar; Amir Maleksabet; Ramin Saadatian Kharajo; Mortaza Taheri‐Anganeh; Saeid Latifi‐Navid

10

Glucose oxidase: Applications, sources, and recombinant production

Biotechnology and Applied Biochemistry 69(3) (2022)

Seyyed Hossein Khatami; Omid Vakili; Nahid Ahmadi; Elahe Soltani Fard; Pegah Mousavi; Bahman Khalvati; Amir Maleksabet; Amir Savardashtaki; Mortaza Taheri‐Anganeh; Ahmad Movahedpour

11

Laccase: Various types and applications

Biotechnology and Applied Biochemistry 69(6) (2022)

Seyyed Hossein Khatami; Omid Vakili; Ahmad Movahedpour; Zeinab Ghesmati; Hassan Ghasemi; Mortaza Taheri‐Anganeh

12

Design and evaluation of a multi-epitope vaccine for COVID-19: an in silico approach

Health Science Monitor 2(3) (2023)

Mehdi Tourani; Sadra Samavarchi Tehrani; Ahmad Movahedpour; Sahar Rezaei Arablouydareh; Amir Maleksabet; Amir Savardashtaki; Hojat Ghasemnejad‐Berenji; Mortaza Taheri-Anganeh

13

Oncolytic bacteria: A revolutionary approach to cancer therapy

Open Life Sciences 20(1) (2025)

Mohsen A. Khormi; Saleh M. Al-maaqar; Abdulaziz R. Al Johni; Nasser A. Al-Tayyar; Jafar Abdullah Alhamad; Abdullah A. Ghyathuddin; Zakia Alblawi; Sabreen M. Behairy; Mohammed A. Alghamdi; Wael A. Alsubhi; Mikiyas D. Teklemariam

15

Bacteria-derived chimeric toxins as potential anticancer agents

Frontiers in Oncology 12 (2022)

Saeed Khoshnood; Hadis Fathizadeh; Foroogh Neamati; Babak Negahdari; Piyush Baindara; Mohd Azmuddin Abdullah; Mohammad Hossein Haddadi

16

Bispecific Antibodies in Colorectal Cancer Therapy: Recent Insights and Emerging Concepts

Immunotherapy 13(16) (2021)

Farideh Ghalamfarsa; Seyyed Hossein Khatami; Omid Vakili; Mortaza Taheri-Anganeh; Amir Tajbakhsh; Amir Savardashtaki; Yousef Fazli; Leila Rezaei Uonaki; Zahra Shabaninejad; Ahmad Movahedpour; Ghasem Ghalamfarsa